Apart from its role in physiological development and homeostasis, reverse signaling has also been described in tumor progression showing diverse effects, for example breast cancer-associated angiogenesis [34] and increased glioma cell motility via ephrin-B2 [35]. This evidence concerns the gene EFNB2 and central nervous system cancer.